Business Wire: latest releases

News releases provided by Business Wire Business Wire.

REPLY: The Board of Directors Approves the Quarterly Report Dated 31 March 2021

Friday, May 14, 2021 - 11:49am

The net financial position on 31 December 2020 was positive for \xe2\x82\xac158.7 million.\n\xe2\x80\x9c"The first quarter of 2021 - stated Mario Rizzante, Reply\'s Chairman - was very positive, both in terms of revenue and margin growth.

Key Points: 
  • The net financial position on 31 December 2020 was positive for \xe2\x82\xac158.7 million.\n\xe2\x80\x9c"The first quarter of 2021 - stated Mario Rizzante, Reply\'s Chairman - was very positive, both in terms of revenue and margin growth.
  • These results were possible thanks to our exclusive focus on new technological specialisation niches and the resilience of our network model.
  • "\n"Today - continues Mario Rizzante - the evolution of the pandemic is still influencing economic performance.
  • Reply services include: Consulting, System Integration and Digital Services www.reply.com\nThis press release is a translation, the Italian version will prevail.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005237/en/\n'

UK-Continental Quarterly Freightstat Seasonal and Forecast Service - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:48am

b'The "Freightstat Seasonal and Forecast Report" report has been added to ResearchAndMarkets.com\'s offering.\nThe freight report (and associated spreadsheet) shows seasonally adjusted total freight data for the main ferry routes based on the monthly figures generated by IRN\'s monthly freight survey (Freightstat).

Key Points: 
  • b'The "Freightstat Seasonal and Forecast Report" report has been added to ResearchAndMarkets.com\'s offering.\nThe freight report (and associated spreadsheet) shows seasonally adjusted total freight data for the main ferry routes based on the monthly figures generated by IRN\'s monthly freight survey (Freightstat).
  • Data is shown for total freight units for the UK-Continental (Short sea and Western Channel) and UK-Ireland (Northern, Central, and Southern).\nData tables are supported by Figures showing the reported, seasonally adjust and trend data.
  • the report shows forecasts for freight for the above routes for the coming 12 months on a monthly basis, with data tables supported by Figure showing the forecast mid-estimates and the upper and lower bounds of the forecasts.\nThe report is published quarterly: January (data to December), May (data to April), July (data to June) and October (data to September).\n'

$12.81 Billion High-Barrier Packaging Film Market - Global Growth, Trends, COVID-19 Impact, and Forecasts 2021-2026 - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:45am

These properties make polypropylene material a good choice for high barrier blister packaging.

Key Points: 
  • These properties make polypropylene material a good choice for high barrier blister packaging.
  • Polypropylene high-barrier films have a high melting point makes it suitable for boilable packages and for sterilizable products.\nMoreover, products packed in thermoforming films have higher product visibility because without compromising with the barrier properties of the packaging.
  • These films are puncture resistance which enables manufacturers to use their products for packaging and can also help in easy transportation.\nFor instance, Aptar Group provides Activ Blister packaging.
  • Companies are investing a large amount of their resources and money in the R&D to innovate new products meeting with the environment and government compliance.\n'

Argo Blockchain and DMG Blockchain Solutions Sign Crypto Climate Accord

Friday, May 14, 2021 - 12:00pm

b"Argo Blockchain Plc (LSE: ARB) (OTCQX US: ARBKF), a UK-based global cryptocurrency mining company, and DMG Blockchain Solutions Inc. (OTCQB US: DMGGF), a vertically integrated blockchain and cryptocurrency technology company, today announced their partnership with the Crypto Climate Accord (CCA) to promote the decarbonization of the cryptocurrency industry.

Key Points: 
  • b"Argo Blockchain Plc (LSE: ARB) (OTCQX US: ARBKF), a UK-based global cryptocurrency mining company, and DMG Blockchain Solutions Inc. (OTCQB US: DMGGF), a vertically integrated blockchain and cryptocurrency technology company, today announced their partnership with the Crypto Climate Accord (CCA) to promote the decarbonization of the cryptocurrency industry.
  • \xe2\x80\x9cPartnering with the Crypto Climate Accord alongside Argo allows us to apply those values to put us on a path to become a more sustainable industry.
  • We look forward to working closely with Argo Blockchain, DMG, and other CCA Supporters to develop this solution and introduce it to the market as quickly as possible.\xe2\x80\x9d\nWith Argo Blockchain, DMG, and over 40 organizations on board - including 20 prominent cryptocurrency organizations - the CCA is on a path to achieve the stated objectives through the promotion and use of renewable energy solutions.
  • DMG\xe2\x80\x99s permissioned blockchain technology is focused on developing enterprise software for the supply chain management of controlled products.

Global Isopropyl Alcohol (IPA) Market Growth, Trends, and Forecasts 2021-2026 - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:37am

b'The "Isopropyl Alcohol (IPA) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com\'s offering.\nDue to COVID-19, the production in various industries, like chemicals, paints and coatings, and others, has decreased.

Key Points: 
  • b'The "Isopropyl Alcohol (IPA) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com\'s offering.\nDue to COVID-19, the production in various industries, like chemicals, paints and coatings, and others, has decreased.
  • Pharmaceutical, personal care, and cosmetics are the major applications of isopropyl alcohol.
  • Companies like Covestro and Lotte Chemicals have been investing in the country\'s chemical industry.
  • Some of the major players in the market include Royal Dutch Shell PLC, LG Chem, Exxon Mobil Corporation, Dow, and LyondellBasell Industries Holdings BV, among others.\n'

Global Mining Equipment Market Growth, Trends, and Forecasts 2021-2026 with Competitive Landscape Analysis of Caterpillar, Komatsu, Liebherr Group, Sandvik, Hitachi, & Atlas Copco - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:33am

Significant price drops were observed across major commodities, while in some cases, prices remain passive.

Key Points: 
  • Significant price drops were observed across major commodities, while in some cases, prices remain passive.
  • Increased investment, along with government support for the digital mine innovation, is expected to trigger the demand for mining equipment over the forecast period.
  • Thus, sales of new mining machinery synced with telematics solutions are expected to drive the mining machinery market.\nThe Mining Equipment Market is characterized by the presence of numerous international and regional players, resulting in a highly competitive market environment.
  • Many competitors in the mining equipment market adopted acquisition and business expansion as their key developmental strategies to develop their geographical foothold and promote their product technologies.\n'

Global Toluene Market Growth, Trends, and Forecasts 2021-2026 - Increasing Demand for Benzene & Xylene for Solvent Applications - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:31am

b'The "Toluene Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com\'s offering.\nThe market for toluene is expected to register a CAGR of about 5%, during the forecast period.\nOne of the major factors driving the market studied is the growing usage of toluene as a solvent.

Key Points: 
  • b'The "Toluene Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com\'s offering.\nThe market for toluene is expected to register a CAGR of about 5%, during the forecast period.\nOne of the major factors driving the market studied is the growing usage of toluene as a solvent.
  • China accounted for the largest market for toluene, in the region.
  • China is the largest producer of chemicals, paints and coatings, and adhesives in the Asia-Pacific region.
  • The major companies include Exxon Mobil Corporation, Chevron Phillips, Lyondellbasell Industries NV, Covestro AG, and BASF SE, among others.\n'

Germany Data Center Market Report 2021: Growth, Trends, and Forecasts 2020-2026 - Key Players are Cisco Systems Inc., IBM Corporation, and Huawei - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:24am

For instance, Vantage acquired Etix to expedite wholesale data center capacity delivery for hyper-scale and enterprise customers looking to expand in Frankfurt.

Key Points: 
  • For instance, Vantage acquired Etix to expedite wholesale data center capacity delivery for hyper-scale and enterprise customers looking to expand in Frankfurt.
  • Such trends are creating a need for efficient IT infrastructure to manage the enormous amounts of data and thus provides growth opportunities for the data center market in Germany.
  • Increased emphasis on digitization from connectivity to data and service architectures is also leading to increased growth of data centers in Germany.
  • Some of the key players in the market are Cisco Systems Inc., IBM Corporation, and Huawei.\n'

Global and China Battery Markets, 2016-2020 & 2021-2026 with Feasibility Study - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:18am

b'The "Global and Chinese Battery Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese Battery Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Battery industry with a focus on the Chinese market.

Key Points: 
  • b'The "Global and Chinese Battery Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese Battery Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Battery industry with a focus on the Chinese market.
  • Then, the report explores the international and Chinese major industry players in detail.
  • The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.\nThe report then estimates 2021-2026 market development trends of the Battery industry.
  • In the end, the report makes some important proposals for a new project of the Battery Industry before evaluating its feasibility.\nOverall, the report provides an in-depth insight of the 2021 global and Chinese Battery industry covering all important parameters.\n'

Global and China Battery Charger Market Report 2021-2026 with Feasibility Study for New Projects - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:13am

b'The "Global and Chinese Battery Charger Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese Battery Charger Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Battery Charger industry with a focus on the Chinese market.

Key Points: 
  • b'The "Global and Chinese Battery Charger Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese Battery Charger Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Battery Charger industry with a focus on the Chinese market.
  • In this part, the report presents the company profile, product specifications, capacity, production value, and 2016-2021 market shares for each company.\nThrough statistical analysis, the report depicts the global and Chinese total market of Battery Charger industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
  • The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.\nThe report then estimates 2021-2026 market development trends of the Battery Charger industry.
  • In the end, the report makes some important proposals for a new project of the Battery Charger Industry before evaluating its feasibility.\nOverall, the report provides an in-depth insight of the 2021 global and Chinese Battery Charger industry covering all important parameters.\n'

Global and Chinese Three Element Li-Ion Battery Cathode Material Industry Report 2021 with Feasibility Study for New Projects - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:10am

b'The "Global and Chinese Three Element Li-Ion Battery Cathode Material Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese Three Element Li-Ion Battery Cathode Material Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Three Element Li-Ion Battery Cathode Material industry with a focus on the Chinese market.

Key Points: 
  • b'The "Global and Chinese Three Element Li-Ion Battery Cathode Material Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese Three Element Li-Ion Battery Cathode Material Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Three Element Li-Ion Battery Cathode Material industry with a focus on the Chinese market.
  • In this part, the report presents the company profile, product specifications, capacity, production value, and 2016-2021 market shares for each company.\nThrough statistical analysis, the report depicts the global and Chinese total market of Three Element Li-Ion Battery Cathode Material industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
  • The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.\nThe report then estimates 2021-2026 market development trends of the Three Element Li-Ion Battery Cathode Material industry.
  • In the end, the report makes some important proposals for a new project of the Three Element Li-Ion Battery Cathode Material Industry before evaluating its feasibility.\nOverall, the report provides an in-depth insight of the 2021 global and Chinese Three Element Li-Ion Battery Cathode Material industry covering all important parameters.\n'

Global and China UV Detector Industry Report 2021-2026 with Proposals for New Projects Included - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:05am

b'The "Global and Chinese Uv Detector Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese UV Detector Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global UV Detector industry with a focus on the Chinese market.

Key Points: 
  • b'The "Global and Chinese Uv Detector Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese UV Detector Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global UV Detector industry with a focus on the Chinese market.
  • Then, the report explores the international and Chinese major industry players in detail.
  • The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.\nThe report then estimates 2021-2026 market development trends of the UV Detector industry.
  • In the end, the report makes some important proposals for a new project of the UV Detector Industry before evaluating its feasibility.\nOverall, the report provides an in-depth insight of the 2021 global and Chinese UV Detector industry covering all important parameters.\n'

General Mills Continues Portfolio Reshaping Strategy with Acquisition of Tyson Foods’ Pet Treats Business

Friday, May 14, 2021 - 11:30am

The business, which includes the Nudges, Top Chews and True Chews brands, is the leader in natural meat treats for pets.\n\xe2\x80\x9cThis acquisition advances our Accelerate strategy and further reshapes our portfolio for growth by adding an attractive business to our fast-growing Pet platform,\xe2\x80\x9d said General Mills Chairman and Chief Executive Officer Jeff Harmening.

Key Points: 
  • The business, which includes the Nudges, Top Chews and True Chews brands, is the leader in natural meat treats for pets.\n\xe2\x80\x9cThis acquisition advances our Accelerate strategy and further reshapes our portfolio for growth by adding an attractive business to our fast-growing Pet platform,\xe2\x80\x9d said General Mills Chairman and Chief Executive Officer Jeff Harmening.
  • \xe2\x80\x9cBy adding these trusted pet treat products to our portfolio, we are strengthening our position in this attractive category.
  • This acquisition is highly complementary to our existing business, combining BLUE\xe2\x80\x99s leading position in natural pet food with Nudges, Top Chews, and True Chews strong portfolio of natural meat treats for pets.
  • As part of the acquisition, General Mills is also acquiring a manufacturing facility in Independence, Iowa.\nThe company intends to fund the acquisition with cash on hand and short-term borrowing.

Global and China Vacuum Blood Collection Tube Industry Report 2021-2026 - ResearchAndMarkets.com

Friday, May 14, 2021 - 11:01am

b'The "Global and Chinese Vacuum Blood Collection Tube Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\nThe \'Global and Chinese Vacuum Blood Collection Tube Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Vacuum Blood Collection Tube industry with a focus on the Chinese market.

Key Points: 
  • b'The "Global and Chinese Vacuum Blood Collection Tube Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com\'s offering.\nThe \'Global and Chinese Vacuum Blood Collection Tube Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Vacuum Blood Collection Tube industry with a focus on the Chinese market.
  • In this part, the report presents the company profile, product specifications, capacity, production value, and 2016-2021 market shares for each company.\nThrough statistical analysis, the report depicts the global and Chinese total market of Vacuum Blood Collection Tube industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
  • The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.\nThe report then estimates 2021-2026 market development trends of the Vacuum Blood Collection Tube industry.
  • In the end, the report makes some important proposals for a new project of the Vacuum Blood Collection Tube Industry before evaluating its feasibility.\nOverall, the report provides an in-depth insight of the 2021 global and Chinese Vacuum Blood Collection Tube industry covering all important parameters.\n'

DFHT Announces Special Meeting of Stockholders to Vote on Business Combination to be held on June 4, 2021

Friday, May 14, 2021 - 11:00am

The definitive proxy statement is being mailed to the Company\xe2\x80\x99s stockholders of record as of the close of business on April 29, 2021 (the \xe2\x80\x9cRecord Date\xe2\x80\x9d).

Key Points: 
  • The definitive proxy statement is being mailed to the Company\xe2\x80\x99s stockholders of record as of the close of business on April 29, 2021 (the \xe2\x80\x9cRecord Date\xe2\x80\x9d).
  • Notice of the Special Meeting will be mailed on or about May 14, 2021.\nYour vote is important no matter how many shares you own.
  • If you are a stockholder of record, you may vote prior to the Special Meeting by signing, dating and mailing your proxy card in the return envelope provided with your proxy material.
  • DFHT\xe2\x80\x99s stockholders and other interested persons are advised to read the definitive proxy statement, in connection with DFHT\xe2\x80\x99s solicitation of proxies for its Special Meeting of stockholders to be held to approve, among other things, the Business Combination, because these documents contain important information about DFHT, CareMax, IMC and the Business Combination.

Momentus Receives Draft National Security Agreement

Friday, May 14, 2021 - 11:30am

b'Momentus Inc. (\xe2\x80\x9cMomentus\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), a U.S. commercial space company that intends to offer transportation and other in-space infrastructure services, today announced that it received a draft National Security Agreement (NSA) from the Committee on Foreign Investment in the United States (CFIUS).

Key Points: 
  • b'Momentus Inc. (\xe2\x80\x9cMomentus\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), a U.S. commercial space company that intends to offer transportation and other in-space infrastructure services, today announced that it received a draft National Security Agreement (NSA) from the Committee on Foreign Investment in the United States (CFIUS).
  • The draft NSA specifies CFIUS\xe2\x80\x99s proposed requirements to resolve its national security concerns about the foreign ownership and control of Momentus.
  • The Company voluntarily filed for CFIUS review to enable CFIUS and its member agencies to scrutinize any and all records of Momentus, and proactively proposed a U.S. national security mitigation plan intended to resolve the national security concerns that CFIUS and its member agencies have raised.\n"The receipt of the draft NSA follows three months of extensive work by the Momentus and SRAC teams," said Momentus President Dr. Fred Kennedy.
  • "The agreement will build on the mitigation plan that we shared with the Department of Defense and other CFIUS member agencies back in February.

India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Friday, May 14, 2021 - 11:01am

A DSMC consists of industry experts with no affiliation to the trial sponsor, which in this case is IGC Pharma, LLC, a subsidiary of IGC.

Key Points: 
  • A DSMC consists of industry experts with no affiliation to the trial sponsor, which in this case is IGC Pharma, LLC, a subsidiary of IGC.
  • The DSMC typically recommends that a trial continue or terminate based on the committee\xe2\x80\x99s evaluation of trial safety data.
  • The DSMC for IGC\xe2\x80\x99s trial, having reviewed Cohort 1 data on Alzheimer\xe2\x80\x99s participants, has recommended progressing to Cohort 2.\nIGC\xe2\x80\x99s Phase 1 study is a placebo-controlled Multiple Ascending Dose (MAD) study on individuals suffering from Alzheimer\xe2\x80\x99s disease.
  • This study is also evaluating the pharmacokinetics and genotyping of CYP2C9 polymorphisms to determine impact on THC metabolism.

PharmaEssentia Resubmits Application to the U.S. FDA For Ropeginterferon alfa-2b-njft to Treat Polycythemia Vera (PV)

Friday, May 14, 2021 - 11:00am

Marketed as Besremi\xc2\xae in Europe, the product was approved by the European Medicines Agency (EMA) in 2019.

Key Points: 
  • Marketed as Besremi\xc2\xae in Europe, the product was approved by the European Medicines Agency (EMA) in 2019.
  • The molecule was invented and is manufactured by PharmaEssentia.\nPharmaEssentia Corporation (TPEx: 6446), based in Taipei, Taiwan, is a rapidly growing biopharmaceutical innovator.
  • Any forward-looking statements set forth in this press release speak only as of the date of this press release.
  • We do not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof.

Western Union to Present at the Barclays Emerging Payments & Fintech Forum

Friday, May 14, 2021 - 11:00am

b'The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today announced that the Company will present at the Barclays Emerging Payments & Fintech Forum on Thursday, May 20, 2021.

Key Points: 
  • b'The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today announced that the Company will present at the Barclays Emerging Payments & Fintech Forum on Thursday, May 20, 2021.
  • The archived webcast will be available shortly after the conclusion of the presentation.\nThe Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments.
  • Western Union\xe2\x80\x99s platform provides seamless cross-border flows and its leading global financial network bridges more than 200 countries and territories and over 130 currencies.
  • Western Union connects the world to bring boundless possibilities within reach.

WEX to Present at Investor Conferences in May

Friday, May 14, 2021 - 11:30am

b'WEX (NYSE:WEX), a leading financial technology service provider, today announced it will present at the following investor conferences in the month of May:\nA webcast of the presentation will be available live on the Investor Relations section of the Company\xe2\x80\x99s website, www.wexinc.com , or through the following address: https://kvgo.com/barclays/wex-inc-may-2021 .\nOn Tuesday, May 25, Chair and Chief Executive Officer, Melissa Smith, will present at the 49th Annual J.P. Morgan Global Technology, Media and Communications Conference at approximately 4:25 PM EDT (1:25 PM PDT).\nAn audio webcast of the presentation will be available live on the Investor Relations section of the Company\xe2\x80\x99s website, www.wexinc.com , or through the following address: https://jpmorgan.metameetings.net/events/tmc21/sessions/37977-wex-inc/we... .\nFor those unable to listen to the live webcasts, an audio replay of both Conferences will also be available on the Company\xe2\x80\x99s website for approximately 90 days.\nPowered by the belief that complex payment systems can be made simple, WEX (NYSE: WEX) is a leading financial technology service provider across a wide spectrum of sectors, including fleet, corporate payments, travel and health.

Key Points: 
  • b'WEX (NYSE:WEX), a leading financial technology service provider, today announced it will present at the following investor conferences in the month of May:\nA webcast of the presentation will be available live on the Investor Relations section of the Company\xe2\x80\x99s website, www.wexinc.com , or through the following address: https://kvgo.com/barclays/wex-inc-may-2021 .\nOn Tuesday, May 25, Chair and Chief Executive Officer, Melissa Smith, will present at the 49th Annual J.P. Morgan Global Technology, Media and Communications Conference at approximately 4:25 PM EDT (1:25 PM PDT).\nAn audio webcast of the presentation will be available live on the Investor Relations section of the Company\xe2\x80\x99s website, www.wexinc.com , or through the following address: https://jpmorgan.metameetings.net/events/tmc21/sessions/37977-wex-inc/we... .\nFor those unable to listen to the live webcasts, an audio replay of both Conferences will also be available on the Company\xe2\x80\x99s website for approximately 90 days.\nPowered by the belief that complex payment systems can be made simple, WEX (NYSE: WEX) is a leading financial technology service provider across a wide spectrum of sectors, including fleet, corporate payments, travel and health.
  • WEX has offices in more than 10 countries and employs more than 5,200 associates around the world.
  • WEX fleet cards offer approximately 16 million vehicles exceptional payment security and control; purchase volume in travel and corporate solutions was $20.9 billion in 2020 and was processed in over 20 currencies; our health division provides consumer-directed healthcare technology and services, and reached an estimated 34.3 million U.S. consumers as of March 31, 2021.
  • For more information, visit www.wexinc.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005079/en/\n'

ICL to Participate in BMO’s 16th Annual Farm to Market Conference

Friday, May 14, 2021 - 12:00pm

b"ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals and chemicals company, today announced Raviv Zoller, president and CEO of ICL, will be presenting at BMO\xe2\x80\x99s 16th Annual Farm to Market Conference at 9:20 a.m.

Key Points: 
  • b"ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals and chemicals company, today announced Raviv Zoller, president and CEO of ICL, will be presenting at BMO\xe2\x80\x99s 16th Annual Farm to Market Conference at 9:20 a.m.
  • ET on Wednesday, May 19, 2021.\nA webcast of the event will be available at investors.icl-group.com/reports-news-and-events/default.aspx#events.
  • ICL leverages its unique bromine, potash and phosphate resources, its passionate team of talented employees, and its strong focus on R&D and technological innovation to drive growth across its end markets.
  • ICL shares are dually listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL).

Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Friday, May 14, 2021 - 11:05am

b'Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the \xe2\x80\x9cCompany\xe2\x80\x9d) today announced that members of the executive management team will participate in two upcoming investor conferences:\nRBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 10:55 a.m.

Key Points: 
  • b'Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the \xe2\x80\x9cCompany\xe2\x80\x9d) today announced that members of the executive management team will participate in two upcoming investor conferences:\nRBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 10:55 a.m.
  • ET; and\nOppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 10:45 a.m. ET.\nIn order to participate in the audio webcast, interested parties can access the live webcast under "News/Events\xe2\x80\x9d through the \xe2\x80\x9cInvestors\xe2\x80\x9d section of the Aurinia corporate website at www.auriniapharma.com .
  • The Company has introduced LUPKYNIS\xe2\x84\xa2 (voclosporin), the first FDA-approved oral therapy dedicated for the treatment of adult patients with active lupus nephritis (LN).
  • The Company\xe2\x80\x99s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005073/en/\n'

OneMain Holdings to Present at Wells Fargo 2021 Virtual Financial Services Investor Conference

Friday, May 14, 2021 - 11:50am

b'OneMain Holdings, Inc. (NYSE: OMF) announced today that Doug Shulman, Chairman and CEO, and Micah Conrad, CFO, will present at the Wells Fargo Virtual Financial Services Conference at 10:40 a.m. Eastern Time on Thursday, May 20, 2021.\nThe general public is invited to listen to the live audio webcast through the Investor Relations section of OneMain\xe2\x80\x99s website at http://investor.onemainfinancial.com .

Key Points: 
  • b'OneMain Holdings, Inc. (NYSE: OMF) announced today that Doug Shulman, Chairman and CEO, and Micah Conrad, CFO, will present at the Wells Fargo Virtual Financial Services Conference at 10:40 a.m. Eastern Time on Thursday, May 20, 2021.\nThe general public is invited to listen to the live audio webcast through the Investor Relations section of OneMain\xe2\x80\x99s website at http://investor.onemainfinancial.com .
  • The replay of the conference call will be available via audio webcast through August 18, 2021.\nOneMain Financial (NYSE: OMF) has been offering responsible and transparent loans for over 100 years.
  • With approximately 1,500 locations throughout 44 states, the company is committed to helping people with their personal loan needs.
  • OneMain and its team members are dedicated to the communities where they live and work.

Metagenomi Presents Findings on Three New CRISPR-associated Gene Editing Systems and their Ability to Edit T-Cell and NK-Cell Genomes for Use in Cell Therapy

Friday, May 14, 2021 - 11:00am

Cost, Ph.D., Senior Director of Biology at Metagenomi, showed that the three CRISPR-associated gene editing systems produced extremely high-frequency gene editing in primary human T cells and NK cells.

Key Points: 
  • Cost, Ph.D., Senior Director of Biology at Metagenomi, showed that the three CRISPR-associated gene editing systems produced extremely high-frequency gene editing in primary human T cells and NK cells.
  • None of the editing systems adversely affected cell viability.
  • The precision and activity of the gene editing systems will enable efficient engineering and manufacture of allogenic cell therapies, including next-generation CAR Ts, CAR NKs, and TCR-based T cell therapies.
  • Our goal is to revolutionize gene editing and unlock its power for the benefit of patients around the world.

Metagenomi Presents New Findings on CRISPR-Associated Transposases (CAST) that Allow for Targetable Genomic Integration of Large DNA Fragments

Friday, May 14, 2021 - 11:00am

In the presentation given at ASGCT by Daniela S. A. Goltsman, Ph.D., Senior Scientist at Metagenomi, targeted integration by Metagenomi\xe2\x80\x99s CAST system was studied in vitro and integration of the DNA fragment into the target genome was confirmed via PCR amplification and sequencing.

Key Points: 
  • In the presentation given at ASGCT by Daniela S. A. Goltsman, Ph.D., Senior Scientist at Metagenomi, targeted integration by Metagenomi\xe2\x80\x99s CAST system was studied in vitro and integration of the DNA fragment into the target genome was confirmed via PCR amplification and sequencing.
  • CAST natively uses a dual guide RNA, however Metagenomi has developed a smaller, single guide RNA that reduces the size of the system while maintaining targeted integration.
  • Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms.
  • Our goal is to revolutionize gene editing and unlock its power for the benefit of patients around the world.

GRAVITY Interactive, Inc. Announced the Return of Dragon Saga for the European Region

Friday, May 14, 2021 - 12:00pm

View the full release here: https://www.businesswire.com/news/home/20210514005020/en/\nGravity Interactive, Inc., a subsidiary of Gravity Co., Ltd., announced that its PC game Dragon Saga has returned to the European regions including Switzerland, Norway, the UK, and Turkey.

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210514005020/en/\nGravity Interactive, Inc., a subsidiary of Gravity Co., Ltd., announced that its PC game Dragon Saga has returned to the European regions including Switzerland, Norway, the UK, and Turkey.
  • Previous European users are able to reactivate their Dragon Saga accounts.
  • Dragon Saga gives players an enchanting and vast world to explore with its fast-paced combat, extraordinary skills, massive bosses, and dungeons.
  • Dragon Saga gives players an enchanting and vast world to explore with its fast-paced combat, extraordinary skills, massive bosses, and dungeons.

Global Coagulation Testing Market Report 2021: Market to Reach $3.5 Billion by 2027 - Instruments Segment to Account for $679 Million - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:58am

b'The "Coagulation Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com\'s offering.\nAmid the COVID-19 crisis, the global market for Coagulation Testing estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 7.7% over the period 2020-2027.\nInstruments, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$679 Million by the end of the analysis period.

Key Points: 
  • b'The "Coagulation Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com\'s offering.\nAmid the COVID-19 crisis, the global market for Coagulation Testing estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 7.7% over the period 2020-2027.\nInstruments, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$679 Million by the end of the analysis period.
  • After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 8% CAGR for the next 7-year period.\nThe U.S. Market is Estimated at $571.3 Million, While China is Forecast to Grow at 11.5% CAGR\nThe Coagulation Testing market in the U.S. is estimated at US$571.3 Million in the year 2020.
  • China, the world\'s second largest economy, is forecast to reach a projected market size of US$776.6 Million by the year 2027 trailing a CAGR of 11.3% over the analysis period 2020 to 2027.\nAmong the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 6.8% respectively over the 2020-2027 period.
  • Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.\n'

Global Synthetic Betaine Market Trajectory & Analytics Report 2020-2027: Food & Beverage, Animal Feed, Cosmetics, Others - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:49am

China, the world\'s second largest economy, is forecast to reach a projected market size of US$695.4 Million by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027.

Key Points: 
  • China, the world\'s second largest economy, is forecast to reach a projected market size of US$695.4 Million by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027.
  • Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4% respectively over the 2020-2027 period.
  • Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.\nIn the global Cosmetics segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$439.8 Million by the year 2027, while Latin America will expand at a 4.9% CAGR through the analysis period.\n'

Global 3D Printing Plastics Market Report 2021: Market to Reach $2.3 Billion by 2027 - Photopolymers is Projected to Account for $1.4 Billion - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:45am

b'The "3D Printing Plastics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com\'s offering.\nAmid the COVID-19 crisis, the global market for 3D Printing Plastics estimated at US$623.4 Million in the year 2020, is projected to reach a revised size of US$2.3 Billion by 2027, growing at a CAGR of 20.5% over the analysis period 2020-2027.\nPhotopolymers, one of the segments analyzed in the report, is projected to record a 20.8% CAGR and reach US$1.4 Billion by the end of the analysis period.

Key Points: 
  • b'The "3D Printing Plastics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com\'s offering.\nAmid the COVID-19 crisis, the global market for 3D Printing Plastics estimated at US$623.4 Million in the year 2020, is projected to reach a revised size of US$2.3 Billion by 2027, growing at a CAGR of 20.5% over the analysis period 2020-2027.\nPhotopolymers, one of the segments analyzed in the report, is projected to record a 20.8% CAGR and reach US$1.4 Billion by the end of the analysis period.
  • Within Europe, Germany is forecast to grow at approximately 14.4% CAGR.\nIn the global Polylactic Acid segment, USA, Canada, Japan, China and Europe will drive the 16.8% CAGR estimated for this segment.
  • These regional markets accounting for a combined market size of US$32.4 Million in the year 2020 will reach a projected size of US$96 Million by the close of the analysis period.\nChina will remain among the fastest growing in this cluster of regional markets.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$269.3 Million by the year 2027.\n'

KBRA Affirms the Ratings for Zinnia Finance DAC

Friday, May 14, 2021 - 10:43am

b'Kroll Bond Rating Agency UK Limited (KBRA) affirms the ratings for five classes of notes issued by Zinnia Finance DAC.

Key Points: 
  • b'Kroll Bond Rating Agency UK Limited (KBRA) affirms the ratings for five classes of notes issued by Zinnia Finance DAC.
  • Since the transaction closed, the rated notes have received timely distributions of interest payments.\nZinnia Finance DAC is a CLO managed by Redding Ridge Asset Management (UK) LLC (RRAM UK or the collateral manager).
  • The ratings reflect current credit enhancement levels, excess spread, coverage tests including par value and interest coverage tests, and a reinvestment overcollateralisation test.\nThe collateral in Zinnia Finance DAC mainly consists of broadly syndicated leveraged loans issued by corporate obligors diversified across sectors.
  • The ratings have been transferred to KBRA UK as a result of regulatory requirements that came into force on 31 December 2020.\nClick here to view the report.

Global Urinary Tract Infections Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:40am

b'The "Global Urinary Tract Infections Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Urinary Tract Infections Epidemiology and Patient Flow Analysis - 2021, provides Urinary Tract Infections epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Urinary Tract Infections Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Urinary Tract Infections Epidemiology and Patient Flow Analysis - 2021, provides Urinary Tract Infections epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Urinary Tract Infections patients, history of the disease at the population level (Urinary Tract Infections prevalence, Urinary Tract Infections incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nUrinary Tract Infections patient flow: Urinary Tract Infections prevalence, diagnosed, and drug-treated patients\nDemographics: Urinary Tract Infections patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Urinary Tract Infections market sizing, assessing market potential, and developing drug forecast models\nIdentify Urinary Tract Infections patients segments through age groups, gender, and disease sub-types\nEvaluate Urinary Tract Infections market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005206/en/\n'

Global Hodgkin Lymphoma Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:38am

b'The "Global Hodgkin Lymphoma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Hodgkin Lymphoma Epidemiology and Patient Flow Analysis - 2021, provides Hodgkin Lymphoma epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Hodgkin Lymphoma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Hodgkin Lymphoma Epidemiology and Patient Flow Analysis - 2021, provides Hodgkin Lymphoma epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Hodgkin Lymphoma patients, history of the disease at the population level (Hodgkin Lymphoma prevalence, Hodgkin Lymphoma incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Hodgkin Lymphoma patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Hodgkin Lymphoma market sizing, assessing market potential, and developing drug forecast models\nIdentify Hodgkin Lymphoma patients segments through age groups, gender, and disease sub-types\nEvaluate Hodgkin Lymphoma market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005205/en/\n'

Global Specialty Oleochemicals Market Report 2021-2027: Market to Reach $32.1 Billion by 2027 - Glycerol Esters is Projected to Account for $13.6 Billion - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:29am

b'World 15-Year Perspective for Specialty Oleochemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Glycerol Esters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Specialty Esters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Alkoxylates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Fatty Amines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Consumer Goods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Healthcare & Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Personal Care & Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Food Processing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Paints & Inks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\n'

Key Points: 
  • b'World 15-Year Perspective for Specialty Oleochemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Glycerol Esters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Specialty Esters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Alkoxylates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Fatty Amines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Consumer Goods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Healthcare & Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Personal Care & Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Food Processing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\nWorld 15-Year Perspective for Paints & Inks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027\n'

Global Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) Market Trajectory & Analytics Report 2021 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:26am

b'The "Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com\'s offering.\nAmid the COVID-19 crisis, the global market for Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027.\nOrthopedics, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$2.3 Billion by the end of the analysis period.

Key Points: 
  • b'The "Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com\'s offering.\nAmid the COVID-19 crisis, the global market for Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027.\nOrthopedics, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$2.3 Billion by the end of the analysis period.
  • After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Dental segment is readjusted to a revised 7.6% CAGR for the next 7-year period.\nThe U.S. Market is Estimated at $603.9 Million, While China is Forecast to Grow at 10.4% CAGR\nThe Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) market in the U.S. is estimated at US$603.9 Million in the year 2020.
  • Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.\nIn the global ENT segment, USA, Canada, Japan, China and Europe will drive the 6.4% CAGR estimated for this segment.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$484.4 Million by the year 2027, while Latin America will expand at a 8.5% CAGR through the analysis period.\n'

Global Brain Cancer Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:20am

b'The "Global Brain Cancer Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Brain Cancer Epidemiology and Patient Flow Analysis - 2021, provides Brain Cancer epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Brain Cancer Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Brain Cancer Epidemiology and Patient Flow Analysis - 2021, provides Brain Cancer epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Brain Cancer patients, history of the disease at the population level (Brain Cancer prevalence, Brain Cancer incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Brain Cancer patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Brain Cancer market sizing, assessing market potential, and developing drug forecast models\nIdentify Brain Cancer patients segments through age groups, gender, and disease sub-types\nEvaluate Brain Cancer market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005195/en/\n'

Global Renal Fibrosis Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:19am

b'The "Global Renal Fibrosis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Renal Fibrosis Epidemiology and Patient Flow Analysis - 2021, provides Renal Fibrosis epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Renal Fibrosis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Renal Fibrosis Epidemiology and Patient Flow Analysis - 2021, provides Renal Fibrosis epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Renal Fibrosis patients, history of the disease at the population level (Renal Fibrosis prevalence, Renal Fibrosis incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Renal Fibrosis patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Renal Fibrosis market sizing, assessing market potential, and developing drug forecast models\nIdentify Renal Fibrosis patients segments through age groups, gender, and disease sub-types\nEvaluate Renal Fibrosis market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005194/en/\n'

Global Glioma Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:17am

b'The "Global Glioma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Glioma Epidemiology and Patient Flow Analysis - 2021, provides Glioma epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Glioma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Glioma Epidemiology and Patient Flow Analysis - 2021, provides Glioma epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Glioma patients, history of the disease at the population level (Glioma prevalence, Glioma incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Glioma patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Glioma market sizing, assessing market potential, and developing drug forecast models\nIdentify Glioma patients segments through age groups, gender, and disease sub-types\n'

Global Limb-Girdle Muscular Dystrophy Markets, Epidemiology and Patient Flow Analysis Report 2021 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:16am

b'The "Global Limb-Girdle Muscular Dystrophy Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Limb-Girdle Muscular Dystrophy Epidemiology and Patient Flow Analysis - 2021, provides Limb-Girdle Muscular Dystrophy epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Limb-Girdle Muscular Dystrophy Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Limb-Girdle Muscular Dystrophy Epidemiology and Patient Flow Analysis - 2021, provides Limb-Girdle Muscular Dystrophy epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Limb-Girdle Muscular Dystrophy patients, history of the disease at the population level (Limb-Girdle Muscular Dystrophy prevalence, Limb-Girdle Muscular Dystrophy incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nLimb-Girdle Muscular Dystrophy patient flow: Limb-Girdle Muscular Dystrophy prevalence, diagnosed, and drug-treated patients\nDemographics: Limb-Girdle Muscular Dystrophy patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Limb-Girdle Muscular Dystrophy market sizing, assessing market potential, and developing drug forecast models\nIdentify Limb-Girdle Muscular Dystrophy patients segments through age groups, gender, and disease sub-types\nEvaluate Limb-Girdle Muscular Dystrophy market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005192/en/\n'

Global Systemic Lupus Erythematosus Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:13am

b'The "Global Systemic Lupus Erythematosus Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Systemic Lupus Erythematosus Epidemiology and Patient Flow Analysis - 2021, provides Systemic Lupus Erythematosus epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Systemic Lupus Erythematosus Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Systemic Lupus Erythematosus Epidemiology and Patient Flow Analysis - 2021, provides Systemic Lupus Erythematosus epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Systemic Lupus Erythematosus patients, history of the disease at the population level (Systemic Lupus Erythematosus prevalence, Systemic Lupus Erythematosus incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nSystemic Lupus Erythematosus patient flow: Systemic Lupus Erythematosus prevalence, diagnosed, and drug-treated patients\nDemographics: Systemic Lupus Erythematosus patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Systemic Lupus Erythematosus market sizing, assessing market potential, and developing drug forecast models\nIdentify Systemic Lupus Erythematosus patients segments through age groups, gender, and disease sub-types\nEvaluate Systemic Lupus Erythematosus market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005191/en/\n'

Global Malaria Markets, Epidemiology and Patient Flow Report 2020-2035 - Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:11am

b'The "Global Malaria Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Malaria Epidemiology and Patient Flow Analysis - 2021, provides Malaria epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Malaria Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Malaria Epidemiology and Patient Flow Analysis - 2021, provides Malaria epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Malaria patients, history of the disease at the population level (Malaria prevalence, Malaria incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Malaria patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Malaria market sizing, assessing market potential, and developing drug forecast models\nIdentify Malaria patients segments through age groups, gender, and disease sub-types\n'

Global Neuroblastoma Markets, Epidemiology and Patient Flow Report 2020-2035 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:08am

b'The "Global Neuroblastoma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Neuroblastoma Epidemiology and Patient Flow Analysis - 2021, provides Neuroblastoma epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Neuroblastoma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Neuroblastoma Epidemiology and Patient Flow Analysis - 2021, provides Neuroblastoma epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Neuroblastoma patients, history of the disease at the population level (Neuroblastoma prevalence, Neuroblastoma incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Neuroblastoma patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Neuroblastoma market sizing, assessing market potential, and developing drug forecast models\nIdentify Neuroblastoma patients segments through age groups, gender, and disease sub-types\n'

Global Gout Markets, Epidemiology and Patient Flow Report 2020-2035: Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:05am

b'The "Global Gout Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThe research report, Global Gout Epidemiology and Patient Flow Analysis - 2021, provides Gout epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Gout Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThe research report, Global Gout Epidemiology and Patient Flow Analysis - 2021, provides Gout epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Gout patients, history of the disease at the population level (Gout prevalence, Gout incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Gout patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Gout market sizing, assessing market potential, and developing drug forecast models\nIdentify Gout patients segments through age groups, gender, and disease sub-types\n'

Global Rheumatoid Arthritis Markets, Epidemiology and Patient Flow Report 2020-2035 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:03am

b'The "Global Rheumatoid Arthritis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2021, provides Rheumatoid Arthritis epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Rheumatoid Arthritis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2021, provides Rheumatoid Arthritis epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Rheumatoid Arthritis patients, history of the disease at the population level (Rheumatoid Arthritis prevalence, Rheumatoid Arthritis incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Rheumatoid Arthritis patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Rheumatoid Arthritis market sizing, assessing market potential, and developing drug forecast models\nIdentify Rheumatoid Arthritis patients segments through age groups, gender, and disease sub-types\nEvaluate Rheumatoid Arthritis market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005184/en/\n'

Global Hepatitis B Epidemiology and Patient Flow Report 2021 - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:02am

b'The "Global Hepatitis B Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Hepatitis B Epidemiology and Patient Flow Analysis - 2021, provides Hepatitis B epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Hepatitis B Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Hepatitis B Epidemiology and Patient Flow Analysis - 2021, provides Hepatitis B epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Hepatitis B patients, history of the disease at the population level (Hepatitis B prevalence, Hepatitis B incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Hepatitis B patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Hepatitis B market sizing, assessing market potential, and developing drug forecast models\nIdentify Hepatitis B patients segments through age groups, gender, and disease sub-types\nEvaluate Hepatitis B market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005183/en/\n'

PMC Biogenix Announces Price Increase on Armoslip® and Kemamide® Fatty Amides

Friday, May 14, 2021 - 10:00am

b'PMC Biogenix Inc. announces that effective June 1, 2021 or as contracts permit, prices for Armoslip and Kemamide brand primary and secondary fatty amides and bisamides will increase by $1.00 to $3.00 per kilo for all orders, globally; adjusted for currency fluctuations.

Key Points: 
  • b'PMC Biogenix Inc. announces that effective June 1, 2021 or as contracts permit, prices for Armoslip and Kemamide brand primary and secondary fatty amides and bisamides will increase by $1.00 to $3.00 per kilo for all orders, globally; adjusted for currency fluctuations.
  • The Company was built on a sustainable model of growth through innovation while promoting social good.
  • PMC operates from a global manufacturing, innovation and marketing platform with facilities in the Americas, Europe and Asia.
  • More information about PMC and its activities around the world can be found at www.pmc-group.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005117/en/\n'

Unlock Your Business’ Potential and Swallow The Red Pill. You’ll Realize the Key to Success is Right in Front of You – Corporate Culture.

Friday, May 14, 2021 - 10:03am

View the full release here: https://www.businesswire.com/news/home/20210514005110/en/\nWhat can you learn about business operations from 20-year old pop culture phenomena like the movie The Matrix?

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210514005110/en/\nWhat can you learn about business operations from 20-year old pop culture phenomena like the movie The Matrix?
  • The Red Pill Executive is not a typical business book.
  • Yes, we use lots of pop culture analogies as a natural way to unlock your first brain to free your mind.
  • This new paradigm unlocks massive potential for Operations Executives and their team members who have the courage to embrace it.

Global Influenza Markets, Epidemiology and Patient Flow Analysis Report 2020-2035 - Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

Friday, May 14, 2021 - 10:00am

b'The "Global Influenza Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Influenza Epidemiology and Patient Flow Analysis - 2021, provides Influenza epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Influenza Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Influenza Epidemiology and Patient Flow Analysis - 2021, provides Influenza epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Influenza patients, history of the disease at the population level (Influenza prevalence, Influenza incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Influenza patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Influenza market sizing, assessing market potential, and developing drug forecast models\nIdentify Influenza patients segments through age groups, gender, and disease sub-types\n'

Global Hepatitis C Markets, Epidemiology and Patient Flow Analysis Report 2020-2035: Sizing, Market Potential, and Drug Forecast Models - ResearchAndMarkets.com

Friday, May 14, 2021 - 9:58am

b'The "Global Hepatitis C Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Hepatitis C Epidemiology and Patient Flow Analysis - 2021, provides Hepatitis C epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Hepatitis C Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Hepatitis C Epidemiology and Patient Flow Analysis - 2021, provides Hepatitis C epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Hepatitis C patients, history of the disease at the population level (Hepatitis C prevalence, Hepatitis C incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Hepatitis C patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Hepatitis C market sizing, assessing market potential, and developing drug forecast models\nIdentify Hepatitis C patients segments through age groups, gender, and disease sub-types\nEvaluate Hepatitis C market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005181/en/\n'

Global Osteoporosis Markets, Epidemiology and Patient Flow Report 2021 - ResearchAndMarkets.com

Friday, May 14, 2021 - 9:56am

b'The "Global Osteoporosis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Osteoporosis Epidemiology and Patient Flow Analysis - 2021, provides Osteoporosis epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Osteoporosis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Osteoporosis Epidemiology and Patient Flow Analysis - 2021, provides Osteoporosis epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Osteoporosis patients, history of the disease at the population level (Osteoporosis prevalence, Osteoporosis incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Osteoporosis patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Osteoporosis market sizing, assessing market potential, and developing drug forecast models\nIdentify Osteoporosis patients segments through age groups, gender, and disease sub-types\n'

Global Glioblastoma Multiforme Markets, Epidemiology and Patient Flow Report 2020-2035 - Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

Friday, May 14, 2021 - 9:54am

b'The "Global Glioblastoma Multiforme Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Glioblastoma Multiforme Epidemiology and Patient Flow Analysis - 2021, provides Glioblastoma Multiforme epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Glioblastoma Multiforme Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Glioblastoma Multiforme Epidemiology and Patient Flow Analysis - 2021, provides Glioblastoma Multiforme epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Glioblastoma Multiforme patients, history of the disease at the population level (Glioblastoma Multiforme prevalence, Glioblastoma Multiforme incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Glioblastoma Multiforme patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Glioblastoma Multiforme market sizing, assessing market potential, and developing drug forecast models\nIdentify Glioblastoma Multiforme patients segments through age groups, gender, and disease sub-types\nEvaluate Glioblastoma Multiforme market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005179/en/\n'